Premium
Continued rapid growth in 68 Ga applications: update 2013 to June 2014
Author(s) -
Velikyan Irina
Publication year - 2015
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.3250
Subject(s) - positron emission tomography , pet imaging , nuclear medicine , chemistry , medical physics , legislation , radiochemistry , computational biology , medicine , political science , biology , law
The worldwide utilization of 68 Ga‐radionuclide for the fundamental research and clinical applications is growing exponentially. A broad range of 68 Ga‐based imaging agents has been explored during recent years. The development of new clinically useful agents is encouraged by many factors; for example, increasing role of positron emission tomography (PET) in nuclear medicine, discovery of new biomarkers, accessibility of 68 Ga, and establishment of PET radiopharmaceutical regulation and legislation. The focus of this review resides on the reports regarding 68 Ga‐related research and applications published during 2013 to June 2014.